Not the protein, but its location in the cell, determines the onset of leukemia (10 Jul 2008)
Leukemia, or cancer of the bone marrow, strikes some 700 Belgians every year. Scientists are still searching for the cause of many forms of the disease, including T-cell acute lymphoblastic leukemia (T-ALL). Now, VIB researchers connected...
Computer simulations help predict fracture risk (04 Jul 2008) human bone structure. This achievement may lead to better clinical tools to improve... of developing an accurate, powerful and fast method to automate the analysis of bone... applied to the bone. This map shows the clinician exactly where and under what load...
Chemokine Therapeutics announces issuance of U.S. patent (04 Jul 2008) of patients in need of bone marrow or stem cell transplantation. This patent is based... of normal bone marrow stem cells and restores white blood cells, which reduce...
454 sequencing at the forefront of bone marrow and stem cell therapy research (01 Jul 2008) Roche Genome Sequencer FLX System creates new opportunities for HLA research at the Blood Centre Linz, Austria
The Blood Centre Linz, Austria has purchased a Genome Sequencer FLX System from Roche, for use in research on rejection reactions in Bone Marrow and Stem Cell transplantation. Using conventional Sanger sequencing it can take weeks...
Bone Medical further positive results from oral osteoporosis drug trial (14 May 2008) Bone Medical oral drug appears to match the injectable alternative Bone Medical Limited has obtained important positive data on blood levels...) conducted at Qpharm in Brisbane, Australia. Previously, Bone announced... measured for injectable PTH (1-34), during Bone's first clinical trial, while placebo...
Kiadis Pharma receives Orphan Drug Designation for Rhitol(TM) from the FDA (17 Apr 2008)
Kiadis Pharma announced that the U.S. Food and Drug Administration (FDA) has granted its product Rhitol(TM) Orphan Drug Designation for the treatment of chronic Graft versus Host Disease (GvHD). This complication of allogeneic bone marrow...
Pharmalink reports the approval of key patent for chemotherapy drug Busulipo (16 Apr 2008) agent used for myeloablation (severe suppression of bone marrow activity) as a preconditioning regimen to bone marrow stem cell transplantation, for example... malignancies or metabolic disorders and in need of bone marrow transplantation...
Top